US OptionsDetailed Quotes

BLCO240517P12500

Watchlist

0.05
0.000.00%

15min DelayClose May 2 15:24 ET

0.00High0.00Low

Bausch + Lomb Corp. Stock Discussion

Meltyy

Feb 21 21:25

Why Is Emergent BioSolutions (EBS) Stock Up 70% Today?

In today’s market, one of the biggest winners generating outsized interest is $Emergent BioSolutions(EBS.US)$ . This mid-cap biotech company remains a unique turnaround story for investors, and many appear to be placing their bets on this company to come out of the pile as a key winner. Indeed, EBS stock has surged over 70% higher on some intriguing news this afternoon.
The company’s turnaround efforts appear to be receiving a jolt today, wit...

Mett

Sep 14, 2022 09:29

$Bausch + Lomb Corp.(BLCO.US)$
EP 17.19
SL 16.49

Analysts Notebook

Sep 12, 2022 08:36

ColumnsUS Top Rating Updates on 9/12: ADBE, OXY, RBLX, UNP and More

Upgrades
• $Argo Group International(ARGO.US)$ : Compass Point Upgrades to Buy from Neutral - PT $28.50
• $Apache(APA.US)$ : Citigroup Upgrades to Buy from Neutral - PT $58 (from $40)
• $Canadian National Railway(CNI.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $128)
• $Canadian Pacific Railway(CP.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $87 (from $85)
• $Carpenter Technology(CRS.US)$ : Cowen Upgra...

Analysts Notebook

Sep 9, 2022 07:00

ColumnsUS Top Rating Updates on 9/9: MMM, REGN, ENPH, PSNY and More

Analysts Notebook

Jul 26, 2022 06:32

ColumnsTop upgrades and downgrades on 7/26: UBS, ROKU, PARA, CHWY and more

Upgrades
• $Zymergen(ZY.US)$ : JPMorgan Upgrades to Neutral from Underweight
Downgrades
• $Chewy(CHWY.US)$: Wedbush Downgrades to Neutral from Outperform - PT $44 (from $35)
• $Paramount Global-B(PARA.US)$: Goldman Sachs Downgrades to Sell from Buy - PT $20 (from $37)
• $Roku Inc(ROKU.US)$: Wolfe Research Downgrades to Underperform from Peerperform - PT $77
• $UBS Group(UBS.US)$: BofA Securities Downgrades to Neutral from Buy - P...

Jamesim

Jul 25, 2022 07:52

How does your family feel about your trading?
There is no objection, nor complete approval, only a golden sentence: be careful in everything, don't invest too much, pay attention to investment.
Does your family support you in trading?
Support, but of course there is persuasion not to invest too much money, learn from experience first.
If they do, in what ways? How did that help you?
Because my father also invested, due to the difference in the number of shares traded in each lot of US s...

Does your family support you in trading?

Analysts Notebook

Jun 24, 2022 07:18

ColumnsTop upgrades and downgrades on 6/24: CLR, MRO, SGEN, FUL and more

Upgrades
• $American Water Works(AWK.US)$ : Janney Upgrades to Buy from Neutral
• $Becton Dickinson & Co(BDX.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $275
• $Altria(MO.US)$ : Morgan Stanley Upgrades to Equalweight from Underweight - PT $43 (from $47)
• $Middlesex Water(MSEX.US)$ : Janney Upgrades to Buy from Neutral
• $Indonesia Energy(INDO.US)$ : Noble Capital Upgrades to Outperform from Market Perform - PT...

Analysts Notebook

Jun 6, 2022 06:01

ColumnsTop upgrades and downgrades on 6/6

Upgrades
• $Ardagh Metal(AMBP.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $9
• $American Express(AXP.US)$ : Edward Jones Upgrades to Buy from Hold
• $CrowdStrike(CRWD.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $215 (from $195)
• $Lululemon Athletica(LULU.US)$ : Bernstein Upgrades to Market Perform from Underperform - PT $300 (from $260)
• $ResMed(RMD.US)$ : RBC Upgrades to Outperform from Sector Perform - PT $244 (from $...

Analysts Notebook

May 31, 2022 09:47

ColumnsAnalysts' screen on BLCO, SNAP, TSLA, ZM and more

GOLDMAN SACHS
• $Bausch + Lomb Corp.(BLCO.US)$ Goldman Sachs analyst Amit Hazan initiated coverage of Bausch + Lomb with a Neutral rating and $22 price target, implying 22% upside potential. The analyst sees Bausch + Lomb's current offering and pipeline as positioning it well to maintain or expand share in the "attractive and durable' eye care market.
• $Steel Dynamics(STLD.US)$ Goldman Sachs analyst Emily Chieng downgraded Steel Dynamics to Neutral...

Analysts Notebook

May 31, 2022 05:31

ColumnsTop upgrades and downgrades on 5/31

Upgrades
• $Grab Holdings(GRAB.US)$: Bernstein Upgrades to Outperform from Market Perform - PT $3.04
• $Linde(LIN.US)$: Evercore ISI Upgrades to Outperform from In Line - PT $355
• $Magellan Midstream(MMP.US)$: Wells Fargo Upgrades to Overweight from EqualWeight - PT $56 (from $54)
• $Mercury Systems(MRCY.US)$: Baird Upgrades to Outperform from Neutral - PT $72 (from $56)
• $Nurix Therapeutics(NRIX.US)$: Wells Fargo Upgrades to Overweight from EqualWeight - PT...

No comment yet